Last update 31 Oct 2026

NIB-103

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
NIB-103
Target
MSLN
Action
inhibitors
Mechanism
MSLN inhibitors(Mesothelin inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication
Ovarian CancerTriple Negative Breast Cancer
Inactive Indication
Mesothelin positive Solid TumorsMetastatic Solid Tumor
Originator Organization
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
Active Organization
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
Inactive Organization-
License Organization
Takara Bio, Inc.Takara Bio, Inc.Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NIB-103
JPRN-jRCT2033250453
/ SuspendedPhase 1
An Open-Label, Dose Escalation, Phase 1 Study of NIB103 in Adult Participants with Mesothelin-Expressing Advanced or Metastatic Solid Tumors
100 Clinical Results associated with NIB-103
Login to view more data
100 Translational Medicine associated with NIB-103
Login to view more data
100 Patents (Medical) associated with NIB-103
Login to view more data
100 Deals associated with NIB-103
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mesothelin positive Solid TumorsPhase 1
Japan
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
24 Oct 2025
Metastatic Solid TumorPhase 1
Japan
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
24 Oct 2025
Ovarian CancerPhase 1
Japan
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
-
Triple Negative Breast CancerPhase 1
Japan
Noile-Immune Biotech, Inc.Noile-Immune Biotech, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free